TSCAN THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
TSCAN THERAPEUTICS, INC. (TCRX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 5.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-04
- TSCAN THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 5.00%.
- TSCAN THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -5.40%, a 205.88% decline from fiscal 2022.
- TSCAN THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 5.10%, a 24.39% increase from fiscal 2021.
- TSCAN THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 4.10%, a 7.89% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 5.00% 10-K · filed 2026-03-04 | -5.00% 10-K · filed 2025-03-05 |
| 2023-12-31 | -5.40% 10-K · filed 2025-03-05 | 5.40% 10-K · filed 2024-03-06 |
| 2022-12-31 | 5.10% 10-K · filed 2024-03-06 | |
| 2021-12-31 | 4.10% 10-K · filed 2023-03-08 | |
| 2020-12-31 | 3.80% 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |